Demant A/S - Asset Resilience Ratio
Demant A/S (DEMANT) has an Asset Resilience Ratio of -2.59% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2022)
This chart shows how Demant A/S's Asset Resilience Ratio has changed over time. Check Demant A/S strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Demant A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DEMANT market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr-838.00 Million | -2.59% |
| Total Liquid Assets | Dkr-838.00 Million | -2.59% |
Asset Resilience Insights
- Limited Liquidity: Demant A/S maintains only -2.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Demant A/S Industry Peers by Asset Resilience Ratio
Compare Demant A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Demant A/S (2008–2022)
The table below shows the annual Asset Resilience Ratio data for Demant A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | -3.42% | Dkr-1.02 Billion ≈ $-159.74 Million |
Dkr29.86 Billion ≈ $4.67 Billion |
-0.06pp |
| 2021-12-31 | -3.36% | Dkr-836.00 Million ≈ $-130.80 Million |
Dkr24.86 Billion ≈ $3.89 Billion |
+0.06pp |
| 2020-12-31 | -3.42% | Dkr-750.00 Million ≈ $-117.34 Million |
Dkr21.93 Billion ≈ $3.43 Billion |
+0.16pp |
| 2019-12-31 | -3.58% | Dkr-780.00 Million ≈ $-122.04 Million |
Dkr21.80 Billion ≈ $3.41 Billion |
+0.50pp |
| 2018-12-31 | -4.08% | Dkr-731.00 Million ≈ $-114.37 Million |
Dkr17.93 Billion ≈ $2.81 Billion |
-4.48pp |
| 2017-12-31 | 0.41% | Dkr66.00 Million ≈ $10.33 Million |
Dkr16.22 Billion ≈ $2.54 Billion |
+0.34pp |
| 2016-12-31 | 0.07% | Dkr11.00 Million ≈ $1.72 Million |
Dkr15.55 Billion ≈ $2.43 Billion |
-0.01pp |
| 2015-12-31 | 0.08% | Dkr12.00 Million ≈ $1.88 Million |
Dkr14.39 Billion ≈ $2.25 Billion |
+0.42pp |
| 2013-12-31 | -0.34% | Dkr-35.00 Million ≈ $-5.48 Million |
Dkr10.36 Billion ≈ $1.62 Billion |
+6.05pp |
| 2008-12-31 | -6.39% | Dkr-251.00 Million ≈ $-39.27 Million |
Dkr3.93 Billion ≈ $614.30 Million |
-- |
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more